IDH2 mutation accelerates TPO-induced myelofibrosis

Yu-Hung Wang, PhD student at The University of Manchester, shared a post on X about a recent paper by Chien-Chin Lin et al., commenting:

“IDH2 mutation accelerates thrombopoietin (TPO) induced myelofibrosis with enhanced S100a8/a9 and NFκB signaling in vivo.”

IDH2 mutation accelerates TPO-induced myelofibrosis with enhanced S100a8/a9 and NFκB signaling in vivo published in Wiley Online Library.

Authors: Chien-Chin Lin, Chi-Yuan Yao, Yu-Hung Wang, Yueh-Chwen Hsu, Chang-Tsu Yuan, Tsung-Chih Chen, Chia-Lang Hsu, Sze-Hwei Lee, Jhih-Yi Lee, Pin-Tsen Shih, Chein-Jun Kao, Po-Han Chuang, Yuan-Yeh Kuo, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien.

Additional information
Source: Yu-Hung Wang/X